152 related articles for article (PubMed ID: 32236712)
1. Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study.
Younis MH; Fuentes-Rivera L; Summers S; Pretell-Mazzini J
Arch Orthop Trauma Surg; 2021 Mar; 141(3):367-373. PubMed ID: 32236712
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases in Patients With Soft-Tissue Sarcomas: Management and Survival-A SEER Population-Based Cohort Study.
Gonzalez MR; Bryce-Alberti M; Leon-Abarca JA; Pretell-Mazzini J
J Am Acad Orthop Surg Glob Res Rev; 2021 Oct; 5(10):. PubMed ID: 34618750
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
4. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.
Svensson E; Christiansen CF; Ulrichsen SP; Rørth MR; Sørensen HT
BMJ Open; 2017 Sep; 7(9):e016022. PubMed ID: 28893744
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
6. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
7. Detection of the high-risk factors for synchronous bone metastasis in tonsillar squamous cell carcinoma.
Li Y; Hu C
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4619-4625. PubMed ID: 37353591
[TBL] [Abstract][Full Text] [Related]
8. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation.
Guo X; Xu Y; Wang X; Lin F; Wu H; Duan J; Xiong Y; Han X; Baklaushev VP; Xiong S; Chekhonin VP; Peltzer K; Wang G; Zhang C
Med Sci Monit; 2019 Feb; 25():1105-1112. PubMed ID: 30739123
[TBL] [Abstract][Full Text] [Related]
9. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
[TBL] [Abstract][Full Text] [Related]
10. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
[TBL] [Abstract][Full Text] [Related]
11. Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study.
Guo Q; Zhang C; Guo X; Tao F; Xu Y; Feng G; Han X; Ren Z; Zhang H; Zhang P; Wang X; Wang G
Cancer Manag Res; 2018; 10():2935-2944. PubMed ID: 30214288
[TBL] [Abstract][Full Text] [Related]
12. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study.
Zhang C; Guo X; Peltzer K; Ma W; Qi L; Zhang Y; Han X; Baklaushev VP; Yao Y; Wang G; Chekhonin VP; Wang X; Ma Y
J Cancer; 2019; 10(14):3133-3139. PubMed ID: 31289583
[No Abstract] [Full Text] [Related]
15. A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study.
Guan X; Ma CX; Quan JC; Li S; Zhao ZX; Chen HP; Yang M; Liu Z; Jiang Z; Wang XS
BMC Cancer; 2019 Jul; 19(1):704. PubMed ID: 31315606
[TBL] [Abstract][Full Text] [Related]
16. The Epidemiology of Lung Metastases.
Chen H; Stoltzfus KC; Lehrer EJ; Horn SR; Siva S; Trifiletti DM; Meng MB; Verma V; Louie AV; Zaorsky NG
Front Med (Lausanne); 2021; 8():723396. PubMed ID: 34616754
[No Abstract] [Full Text] [Related]
17. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prognostic factors for inflammatory breast cancer with bone metastasis: A population-based study.
Gao T; Shao F
J Orthop Surg (Hong Kong); 2021; 29(2):23094990211000144. PubMed ID: 34060362
[TBL] [Abstract][Full Text] [Related]
20. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
Reddy SP; Dowell JE; Pan E
Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
